Combination chemotherapy in small cell lung carcinoma: A randomized study of two intensive regimens

S Lowenbraun, R Birch, R Buchanan, S Krauss… - Cancer, 1984 - Wiley Online Library
… In conclusion, both of the intensive chemotherapy programs employed in this study have
impressive overall response rates and modest complete response rates in extensive SCLC. …

An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer.

J Ensley, J Kish, E Tapazoglou, J Jacobs… - Journal of Clinical …, 1988 - ascopubs.org
… of induction regimens. Therefore, a five course, alternating combination chemotherapy induc…
and toxicity of a prolonged, intensive induction regimen in patients with advanced SCC of H …

Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

KH Lee, JH Lee, SJ Choi, M Seol, YS Lee, WK Kim… - Leukemia, 2005 - nature.com
… the same regimen of combination chemotherapy was used … with intensive multiagent
combination chemotherapy. In total, … treated with a combination chemotherapy regimen used in the …

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

RI Fisher, ER Gaynor, S Dahlberg… - … England Journal of …, 1993 - Mass Medical Soc
… The development of curative combination chemotherapy for patients with advanced stages
of … First-generation regimens, which generally included four chemotherapeutic agents, …

Long‐term follow‐up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome

H Kantarjian, M Beran, J Cortes… - … Journal of the …, 2006 - Wiley Online Library
… , intensive chemotherapy regimens were grouped to distinguish anthracycline-cytarabine
regimens from … Among the latter, topotecan plus cytarabine (TA) regimens were considered …

… of adults with Philadelphia chromosome–positive acute lymphoblastic leukemia—from intensive chemotherapy combinations to chemotherapy-free regimens: a …

E Jabbour, FG Haddad, NJ Short, H Kantarjian - JAMA oncology, 2022 - jamanetwork.com
combined with intensive or low-intensity chemotherapy resulted in higher CMR rates compared
with imatinib-based regimens… generation TKI ponatinib was added to chemotherapy. The …

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity.

E Frei 3rd, A Elias, C Wheeler, P Richardson… - Clinical cancer research …, 1998 - AACR
The most important variables for the clinical use of antitumor agents (AAs) are dose and
combination chemotherapy. The objectives of this study were to analyze the relationship …

Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia.

HM Kantarjian, L Vellekoop, KB McCredie… - Journal of Clinical …, 1985 - ascopubs.org
… least two other studies using similar intensive chemotherapy approaches. The use of historical
… by Cunningham et al using an equally intensive regimen, the L5 protocol.However, when …

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate-and …

DW Blayney, ML LeBlanc, T Grogan… - Journal of clinical …, 2003 - ascopubs.org
regimens that included additional chemotherapy drugs. Dose intensification (escalating drug
doses and compressing the administration schedule) of the standard combinationregimen

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.

KG Louie, RF Ozols, CE Myers, Y Ostchega… - Journal of Clinical …, 1986 - ascopubs.org
Sixty-two patients with advanced ovarian adenocarcinoma (stages III and IV) and without
prior chemotherapy or radiotherapy were treated with a four-drug combination consisting of …